2012 Antibiotic Restriction Refinement Rules Released

Recently, the National Plan for the Special Campaign for Clinical Application of Antibacterial Drugs in 2012 issued by the Ministry of Health (hereinafter referred to as “2012 Remediation Plan”) has for the first time clarified the remediation requirements for this year. Under this policy, it is expected that the growth rate of the antibiotic industry this year will continue to be curbed.

Anti-restriction policy

“The 2012 remediation plan cannot be more rigorous than the 2011 version, but the terms are more detailed,” said a senior pharmaceutical industry researcher in Shanghai.

According to the 2011 version of the remediation plan, the antibacterial drugs in the three-level general hospitals shall not exceed 50 in principle. In principle, the antibacterial drugs in the second-level general hospitals shall not exceed 35 types, and those who have been found by random sampling will be punished. This year's 2012 remediation program, while retaining the aforementioned policies, also made detailed requests for the use of antibiotics in specialty hospitals.

According to the latest policy, the number of antibacterial drugs in the oral hospital is not more than 35 in principle. In principle, the number of antibiotics in cancer hospitals should not exceed 35. In principle, the number of antibacterial drugs in children's hospitals should not exceed 50. In principle, the antibacterial drugs in psychiatric hospitals should not exceed Ten kinds of antibacterial drugs in maternity hospitals (including maternal and child care hospitals) do not exceed 40 in principle.

In addition, the remediation program also imposes restrictions on the use of patients. In other words, the use rate of antibiotics in inpatients in general hospitals in the future should not exceed 60%, the proportion of antibiotics in outpatients should not exceed 20%, the proportion of antibiotics in emergency patients must not exceed 40%, and the intensity of antibacterial use must strive to control 40 DDDs per 100 person days. the following.

Antibiotic market will further shrink

"We believe that the tightening of the "resistance limit order" will further shrink the antibiotic market. Enterprises that have been expanding their production of antibiotic materials and intermediates in the past two years will be hit hard." Tianxiang Investment said in a report recently issued that last year The “limitation of resistance” has led to a significant decline in the performance of related companies.

“The implementation of the anti-restriction order in the second half of last year was relatively strict. This can be seen from the report on the performance of antibiotic companies in the third quarter of last year. The sales of most varieties of a large-scale antibiotic company in South China declined significantly. Only one was listed. There has been an “adverse market growth” in the generation of products that restrict the use of catalogues, said the Shanghai-based senior medical researcher.

“This is actually a mandatory regulation. Of course, various companies also have psychological expectations, so they are already prepared. The overall performance of the industry in 2012 will not be worse than in 2011,” said the analyst.

However, the current set of data shows that the use of antibiotics in China still has tremendous room for compression. The data shows that at present, the annual per capita consumption of antibiotics in China is about 138 grams, while the United States is only 13 grams, and the gap is more than 10 times. The annual use rate of antibiotics in our country has exceeded 70%, and the use rate in surgery is almost 90%.